Prescribing costs in UK general practice: The impact of hard budget constraints

被引:5
|
作者
Whynes, DK [1 ]
Baines, DL [1 ]
Tolley, KH [1 ]
机构
[1] UNIV NOTTINGHAM HOSP,SCH PUBL HLTH,NOTTINGHAM NG7 2UH,ENGLAND
关键词
D O I
10.1080/000368497327182
中图分类号
F [经济];
学科分类号
02 ;
摘要
The development of an internal market in UK public sector health care has introduced hard budget constraints for those general practitioner purchasers who elect to hold their own budgets or 'funds'. Prescription medicines constitute an element of the fundholder's budget and a theoretical model is developed to explain how hardening constraints might be expected to impact upon prescribing decisions. The model is based on a trade-off between prescribing and budget surplus and it predicts, intel alia, that both the prescribing costs and volume of medicines prescribed by fundholders will be lower than for non-fundholders. A reduction in X-inefficiency is also predicted, manifested as a higher rate of generic prescribing and the use of computerized prescribing management. The model is found to be consistent with the observed facts in one English health authority (Lincolnshire).
引用
收藏
页码:393 / 399
页数:7
相关论文
共 50 条
  • [1] VARIATIONS IN GENERAL-PRACTICE PRESCRIBING COSTS AND IMPLICATIONS FOR BUDGET SETTING
    HEALEY, AT
    YULE, BF
    REID, JP
    [J]. HEALTH ECONOMICS, 1994, 3 (01) : 47 - 56
  • [2] The impact of nursing home patients on prescribing costs in general practice
    Avery, AJ
    Groom, LM
    Brown, KP
    Thornhill, K
    Boot, D
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1999, 24 (05) : 357 - 363
  • [3] The impact of a general practice group intervention on prescribing costs and patterns
    Walker, J
    Mathers, N
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 2002, 52 (476): : 181 - 186
  • [4] The Prescribing of Fibrates in General Practice in the UK and the Impact of Regulatory Advice
    Donegan, Katherine L.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 289 - 289
  • [5] Modelling prescribing costs in general practice
    Wilson-Davis, K
    Stevenson, WG
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 1999, 8 (01) : 58 - 60
  • [6] Prescribing costs in general practice fundholding
    Wilson, R
    Walley, T
    [J]. LANCET, 1995, 346 (8991-2): : 1710 - 1711
  • [7] Prescribing Trends and Drug Budget Impact of the ARBs in the UK
    Blak, Betina T.
    Mullins, C. Daniel
    Shaya, Fadia T.
    Simoni-Wastila, Linda
    Cooke, Catherine E.
    Weir, Matthew R.
    [J]. VALUE IN HEALTH, 2009, 12 (02) : 302 - 308
  • [8] Predicting prescribing costs in general practice using practice demography
    WilsonDavis, K
    Stevenson, WG
    McGavock, H
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 1997, 6 (03) : 189 - 196
  • [9] FORMULARIES IN GENERAL-PRACTICE - THE EFFECTS ON PRESCRIBING COSTS
    BEARDON, PHG
    BROWN, SV
    MOWAT, DAE
    GRANT, JA
    MCDEVITT, DG
    [J]. ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1986, 59 : 150 - 150
  • [10] Models for predicting prescribing costs in general practice should use per capita practice costs and not total practice costs
    Roberts, SJ
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 1998, 7 (02) : 125 - 126